Showing 1041-1050 of 20386 results for "".
Challenging Cases in IgA Nephropathy and Identifying Patients for Specialized Care
https://reachmd.com/programs/medical-industry-feature/challenging-cases-iga-nephropathy-specialized-care/29536/IgA nephropathy is a heterogeneous disease with variable clinical presentation. Learn more about its pathogenesis, diagnostic considerations, and complex cases as Dr. Jaimini Patel sits down with Dr. Sayna Norouzi, Associate Professor of Medicine and clinical nephrologist at Loma Linda University MeInvasive Fungal Infections: More Common Than You Think
https://reachmd.com/programs/cme/invasive-fungal-infections-more-common-than-you-think/14808/Where do we stand in the battle with invasive fungal infections? Find out why we’re losing ground and how to fight back against the fungus among us.Virtual IBD Clinic: Disease Management and Surgery
https://reachmd.com/programs/cme/virtual-ibd-clinic-disease-management-and-surgery/11489/Explore the case of a young patient with Crohn’s disease (CD) who develops intestinal complications.Modern Obstructive HCM Care: From Unmet Needs to Individualized Myosin Inhibitor Therapy
https://reachmd.com/programs/cme/modern-obstructive-hcm-care-from-unmet-needs-to-individualized-myosin-inhibitor-therapy/56979/Explore how cardiac myosin inhibitors are reshaping obstructive HCM management, from unmet needs to individualized, evidence-based treatment.Practical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases, Ch. 5
https://reachmd.com/programs/the-practical-dermatology-roundtable/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-5/56873/In the fifth installment of this eight-part series, host Ted Lain, MD, MBA, FAAD, and guests Zoe Diana Draelos, MD, and Firas George Hougeir, MD, FAAD, explore how these findings may generalize to other inflammatory skin conditions and reviews the unique properties of the skincare products used in tA New Paradigm in IgAN Management—Advancing Clinical Practice in the Era of Therapeutic Expansion
https://reachmd.com/programs/cme/a-new-paradigm-in-igan-managementadvancing-clinical-practice-in-the-era-of-therapeutic-expansion/54415/On-demand webcast on the latest advances in diagnosing and managing patients with IgA nephropathy (IgAN), including the current data on new and emerging IgAN therapies.Conference Coverage at ICCBH 2026: A New Frontier in Achondroplasia—Clinical Insights From the PROPEL 3 Trial of Oral Infigratinib in Children
https://reachmd.com/clinical-practice/endocrinology/conference-coverage-at-iccbh-2026-a-new-frontier-in-achondroplasiaclinical-insights-from-the-propel-3-trial-of-oral-infigratinib-in-children/57926/Explore the efficacy, safety, and clinical implications of the PROPEL 3 trial evaluating oral infigratinib in children with achondroplasia.Integrating Patient Perspectives in Dermatologic Care
https://reachmd.com/programs/dermconsult/patient-perspectives-dermatologic-care/37245/Clinicians are trying to align care with individual patient needs for the approximately eight million American adults and over 125 million people worldwide living with psoriasis.1 In the ENCOMPASS study’s US arm, researchers examined treatment experiences, satisfaction, and perceptions of therapiesEvaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
https://reachmd.com/programs/project-oncology/evaluating-alemtuzumab-in-adult-all-insights-from-a-phase-12-clinical-trial/32993/Alemtuzumab may have potential as an adult acute lymphoblastic leukemia treatment. Dive deeper into its safety, efficacy, and implications for care.Molecular Precision: How Myosin Inhibitors Redefine Control
https://reachmd.com/programs/cme/molecular-precision-how-myosin-inhibitors-redefine-control/54839/Explore how cardiac myosin inhibitors are reshaping obstructive HCM management, from unmet needs to individualized, evidence-based treatment.